ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

ClinicalTrials.gov ID: NCT02138838

Public ClinicalTrials.gov record NCT02138838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Dialysis

Study identification

NCT ID
NCT02138838
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
55 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2014
Primary completion
Jun 22, 2016
Completion
Jun 22, 2016
Last update posted
Jun 28, 2020

2014 – 2016

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Research Site Los Angeles California 90027
Research Site Wilmington Delaware 19803
Research Site Atlanta Georgia 30322
Research Site Chicago Illinois 60612
Research Site Iowa City Iowa 52242
Research Site Louisville Kentucky 40202
Research Site Baltimore Maryland 21287
Research Site Boston Massachusetts 02115
Research Site Detroit Michigan 48201
Research Site Minneapolis Minnesota 55454
Research Site Jackson Mississippi 39216
Research Site Kansas City Missouri 64108
Research Site St Louis Missouri 63104
Research Site St Louis Missouri 63110
Research Site West Orange New Jersey 07052
Research Site New York New York 10029
Research Site The Bronx New York 10467
Research Site Greenville North Carolina 27834
Research Site Cincinnati Ohio 45229
Research Site Cleveland Ohio 44106
Research Site Columbus Ohio 43205
Research Site Philadelphia Pennsylvania 19104
Research Site Dallas Texas 75235
Research Site Houston Texas 77030
Research Site San Antonio Texas 78229
Research Site Salt Lake City Utah 84113

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02138838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2020 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02138838 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →